Neurology Articles

Neurology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Veauthier J et al. - These findings demonstrate, that a LEV add-on therapy is not associated with a slowing of the EEG background frequency. This is in accordance with neuropsychological reports of the authors' own lab and others showing that LEV add-on therapy has no negative effects on cognitive functions, either.

Related Articles

Pancytopenia Associated with Levetiracetam Treatment
Clinical Drug Investigation, 10/15/09    Relevance Score: 66%

Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia
Lipids in Health and Disease, 10/13/09    Relevance Score: 65%

Casopitant improves the quality of life in patients receiving highly emetogenic chemotherapy
Supportive Care in Cancer, 11/10/09    Relevance Score: 64%

Neonatal Peritoneal Candidiasis Successfully Treated with Anidulafungin Add-On Therapy
Annals of Pharmacotherapy, 10/23/09    Relevance Score: 64%

Issues in postmenopausal hormone therapy: depression, endometrial health, and discontinuation
Sexuality, Reproduction & Menopause, 10/09/09    Relevance Score: 47%

Today in Neuro/Psych pharmacology...keeping you current

Natalizumab treatment in multiple sclerosis: Marked decline of chemokines and cytokines in cerebrospinal fluid
Multiple Sclerosis, 12/11/09

Behavioral Dimensions and Acetylcholinesterase Inhibitor-related Effect in Alzheimer Disease Over Time: A Latent Trajectory Modeling
Cognitive and Behavioral Neurology, 12/11/09

Depression in Parkinson's Disease
Canadian Journal of Neurological Sciences, 12/10/09

Today in Seizure...keeping you current

Association between attention-deficit/hyperactivity disorder and epilepsy in pediatric populations
Expert Review of Neurotherapeutics, 12/11/09

BRD2 and TAP-1 genes and juvenile myoclonic epilepsy
Neurological Sciences, 12/10/09

Refractory Metabolic Acidosis as a Complication of High-Dose Midazolam Infusion for Pediatric Status Epilepticus
Clinical Neuropharmacology, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address